Phase II proof-of-concept trial of simeprevir in combination with VX 135 in treatment-naive patients with chronic genotype 1 hepatitis C
Latest Information Update: 30 Jul 2013
At a glance
- Drugs Simeprevir (Primary) ; VX 135 (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 30 Jul 2013 This trial will commence in the second half of 2013, according to a Vertex media release.
- 06 Jan 2013 Planned initiation date changed from 1 Mar 2013 to 1 Jun 2013, according to a Vertex Pharmaceuticals media release.
- 06 Jan 2013 Data is expected in the second half of 2013, according to a Vertex Pharmaceuticals media release.